Neoadjuvant mFOLFOX6+/- Aflibercept in patients with T3-rectal cancer at low risk for local failure: a randomized phase II trial of the German Rectal Cancer Study Group (ACO/ARO/AIO 0214)
ONCOLOGY RESEARCH AND TREATMENT（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要